Acuitas Therapeutics
Vancouver, BC
Reagent / Material Supplier
Program data pending ClinicalTrials.gov matching
· Last scored 2026-04-29
59.0
Signal Score
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
✓ Press (11)
○ EMA GMP
○ MHRA GMP
Quick Facts: Acuitas Therapeutics
- Signal Score
- 59.0/100 (as of 2026-04-29)
- Quality Compliance
- Assessment pending
- Headquarters
- Vancouver, BC
- Modalities
- mRNA
- Active Programs
- No ClinicalTrials.gov matches confirmed — 6 partnership announcements in press
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About Acuitas Therapeutics
Reagent/raw material supplier.
Signal Score & Pillar Breakdown
Quality Compliance
—
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer. 6 partnership announcements found in press monitoring.
Programs
— no verified data
Sponsors— no verified data
ModalitiesmRNA
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Partnership Announcements (from press monitoring)
Financial Stability
60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
58.0
Strong partnership activity (6 articles)
Sites: Vancouver, BC
Source: SEC EDGAR, press monitoring, company profiles
1 manufacturing site
Recent Press11 articles
Strong partnership activity (6 articles)
Recent News 11 articles
Genflow partners with Acuitas for gene therapy delivery tech By Investing.com - Investing.com Nigeria
Genflow partners with Acuitas for gene therapy delivery tech By Investing.com Investing.com Nigeria
Genflow partners with Acuitas for gene therapy delivery tech By Investing.com - Investing.com South Africa
Genflow partners with Acuitas for gene therapy delivery tech By Investing.com Investing.com South Africa
Genflow Secures Fully Funded LNP Collaboration With Acuitas to Advance SIRT6 Gene Therapy - TipRanks
Genflow Secures Fully Funded LNP Collaboration With Acuitas to Advance SIRT6 Gene Therapy TipRanks
Genflow partners with Acuitas for gene therapy delivery tech - Investing.com
Genflow partners with Acuitas for gene therapy delivery tech Investing.com
Genflow partners with Acuitas for gene therapy delivery tech By Investing.com - Investing.com Australia
Genflow partners with Acuitas for gene therapy delivery tech By Investing.com Investing.com Australia
Genflow partners with Acuitas for gene therapy delivery tech By Investing.com - Investing.com UK
Genflow partners with Acuitas for gene therapy delivery tech By Investing.com Investing.com UK
Circio and Acuitas partner on circular RNA CAR T therapy - Drug Target Review
Circio and Acuitas partner on circular RNA CAR T therapy Drug Target Review
Circio enters in vivo cell therapy evaluation agreement with Acuitas Therapeutics - TradingView — Track All Markets
Circio enters in vivo cell therapy evaluation agreement with Acuitas Therapeutics TradingView
Circio, Acuitas Therapeutics to Evaluate In-vivo CAR-T Cell Therapy Technology - marketscreener.com
Circio, Acuitas Therapeutics to Evaluate In-vivo CAR-T Cell Therapy Technology marketscreener.com
Circio enters in vivo cell therapy evaluation agreement with Acuitas Therapeutics - Finansavisen
Circio enters in vivo cell therapy evaluation agreement with Acuitas Therapeutics Finansavisen
Circio Holding ASA And Acuitas Therapeutics Enter In Vivo Car-T Cell Therapy Evaluation Agreement - marketscreener.com
Circio Holding ASA And Acuitas Therapeutics Enter In Vivo Car-T Cell Therapy Evaluation Agreement marketscreener.com
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Evonik Health Care
Birmingham, AL · Vancouver, BC
Signal Score: 81.5
mRNA, Biologics
Precision NanoSystems (Cytiva)
Vancouver, BC
Signal Score: 69.0
mRNA
Pfizer CentreOne
Kalamazoo, MI · McPherson, KS
Signal Score: 91.5
Biologics, mRNA
ReciBioPharm
Keele, UK · Sodertalje, SE
Signal Score: 88.0
AAV, Lentiviral, Plasmid, mRNA
Aldevron
Fargo, ND
Signal Score: 85.3
Plasmid, mRNA